Back

Effectiveness and safety of catheter-directed thrombolysis for pulmonary embolism in key patient subgroups: results of an individual patient level analysis

26 August 2023 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pulmonary vascular intervention: a new world to explore for the interventional cardiologist Pulmonary Embolism (PE) ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Riccardo Fumagalli

University Hospital Zurich, Zurich (Switzerland)

7 More presentations in this session

Presentation thumbnail
Large-bore mechanical thrombectomy for intermediate- and high-risk pulmonary embolism: interim outcomes from the European cohort of the FLASH registry
Professor F. Mahfoud (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Catheter-directed therapies impact on intermediate-high- and high-risk pulmonary embolism patients
Doctor A. Grazina (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Mechanical thrombectomy in intermediate- and high-risk acute pulmonary embolism: haemodynamic outcome at 3 months
Doctor L. Lauder (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Characteristics in patients with adult-onset idiopathic peripheral pulmonary artery stenosis
Doctor Y. Tamura (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Incidence and predictors of in-stent restenosis following intervention for pulmonary vein stenosis due to fibrosing mediastinitis
Professor Y. Cao (Lanzhou, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Pulmonary vascular intervention: a new world to explore for the interventional cardiologist

The Event

Event poster

ESC Congress 2023

26 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Presentation
A meta-analysis of catheter-directed thrombolysis versus standard anticoagulation among patients with intermediate high risk pulmonary embolism
thumbnail
Congress Presentation
Ultrasound assisted, catheter-directed thrombolysis for acute intermediate-high and high risk pulmonary embolism: focus on safety for oncological patients
thumbnail
Congress Presentation
Catheter-directed therapies impact on intermediate-high- and high-risk pulmonary embolism patients

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources